Kotaro Azuma et al. found that tripartite motif-containing (TRIM) 47 could be a predictor of breast cancer recurrence through the analysis of 116 clinical samples of tamoxifen-treated breast cancer. Here, TRAT1 is linked to breast carcinoma.